Atea Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
AVIR
CUSIP
04683R106
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 04683R106 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
15.0% 5/6/2026
Event 3/31/2026
Jean-Pierre Sommadossi 13G/A
11.0% 11/13/2026
Event 9/30/2026
BML Investment Partners, L.P. 13G
9.9% 2/9/2026
Event 12/31/2025
BlackRock, Inc. 13G/A 7.1% 4/23/2025
Event 3/31/2025
Tang Capital Management LLC 13G
6.0% 10/6/2026
Event 10/6/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Radoff Bradley Louis 13D/A
4.0% 4/17/2025
Event 4/16/2025
EcoR1 Capital, LLC 13G/A
4.0% 2/14/2025
Event 12/31/2024
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 130 59.0 M $307M
2026 Q2 125 59.4 M $276M
2026 Q1 127 60.1 M $323M
2025 Q4 111 57.0 M $203M
2025 Q3 115 53.2 M $154M
2025 Q2 108 52.7 M $190M
2025 Q1 106 52.9 M $158M
2024 Q4 109 56.3 M $189M
2024 Q3 109 57.9 M $194M
2024 Q2 106 56.7 M $188M
2024 Q1 114 54.4 M $220M
2023 Q4 109 55.1 M $168M
2023 Q3 120 56.9 M $171M
2023 Q2 134 57.0 M $213M
2023 Q1 131 56.8 M $190M
2022 Q4 134 57.8 M $278M
2022 Q3 127 57.4 M $327M
2022 Q2 130 57.6 M $409M
2022 Q1 131 54.9 M $397M
2021 Q4 150 53.6 M $479M
2021 Q3 148 56.8 M $1.99B
2021 Q2 106 58.9 M $1.27B
2021 Q1 83 49.4 M $3.04B
2020 Q4 70 49.9 M $2.07B